University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
NCT Number: NCT00018824
The purpose of this study is to test the efficacy combining a treatment for depression with a treatment for alcohol dependence.
Looking for future studies?
Notify Me55 year and older
All sexes
Interventional
Phase 4
Philadelphia, Pennsylvania, 19104, United States
This study aims to study 80 patients with comorbid alcohol dependence and a depressive syndrome. After appropriate detoxification, patients are started on either naltrexone 50 mg or placebo. After one week, sertraline is added in an open label fashion. It is hypothesized that those patients receiving combination therapy will last 3 months with follow-up tracking lasting 1 year.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 12 weeks
US Department of Veterans Affairs
Fed
The Treatment of Late Life Major Depression Complication by Alcohol
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02327858
Alcohol-Related Disorders, Alcoholism
Fort McMurray, Alberta, Canada
View Trial DetailsNCT02126696
Alcohol-Related Disorders, Alcoholism
Butha-Buthe, Lesotho
View Trial DetailsNCT00338962
Alcohol-Related Disorders, Alcoholism
West Haven, Connecticut, United States
View Trial DetailsNCT00004554
Alcohol-Related Disorders, Alcoholism
Philadelphia, Pennsylvania, United States
View Trial Details